Project Grant R21AI187982
Award Date 8/1/25
Completion Date 7/31/27
Dollars Obligated $480K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $446,875 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The grant supports research on the nuclear localization and function of the Ebola virus VP40 protein, a critical area for developing novel antiviral countermeasures against Ebola and Marburg viruses. The...
- This federal Project Grant award, valued at $449,625.00 and provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research to determine the morphology of the Lloviu virus (LLOV) virions and compare their structures to those of Ebola virus (EBOV) and Marburg virus (MARV). The research team will utilize cryogenic electron microscopy and tomography techniques to generate...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $441,100 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Mayo Clinic to develop mouse models for studying the life cycle of the Ebola virus (EBOV) under Biosafety Level-2 (BSL-2) conditions. The grant, with a performance period from August 2025 to July 2027, aims to generate two approaches for in vivo EBOV life cycle modeling using virus-like particles and expression of...
- The University of Iowa was awarded a $124,972 Project Grant by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant will support research to evaluate the impact of malaria on the immune response to the Ebola virus vaccine ERVEBO. Utilizing experimental Plasmodium infection models and clinically relevant vaccine administration strategies in mice, the research aims to understand how malaria infection...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $394,320 Project Grant under the Allergy and Infectious Diseases Research (CFDA 93.855) program to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to research how extracellular matrix (ECM) stiffness regulates the NLRP3 inflammasome in macrophages. The objective is to define the mechanisms by which ECM stiffness controls the NLRP3 inflammasome, which is relevant to...
- The federal Project Grant award of $7,037,583 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to understand the mechanisms of nuclear egress in herpesviruses. The grant funds a collaborative research project led by Tufts University School of Medicine to expand structural and functional studies of the nuclear egress complex (NEC) across different herpesvirus families, visualize the...
- The federal Project Grant award of $3,436,588.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research (CFDA 93.855) program. The award supports research to investigate the role of the TLE3 transcription cofactor in regulating the function and persistence of CD8+ T cells during chronic viral infections and cancer. The research aims to molecularly reconstruct the T cell exhaustion process and identify therapeutic...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $238,972 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Research Foundation for the State University of New York, doing business as Sponsored Projects Services, to study the role of the cellular protein EHD4 in restricting HIV-1 infection. The research aims to determine the mechanism by which EHD4 decreases the infectivity of HIV-1 particles by impacting the incorporation of...
- This $536,871 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to identify small molecule inhibitors against critical components of arenaviruses, which cause severe hemorrhagic fevers. The proposed studies aim to use machine learning and molecular screening to identify pan-reactive inhibitors targeting the arenavirus surface glycoprotein and RNA polymerase...
- The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855), awarded a $653,693 Project Grant to Emory University to conduct structural investigations of the HIV-1 virion and the mechanism of the capsid targeting compound lenacapavir. The research aims to leverage advanced cryo-electron microscopy and tomography techniques to study the structural details of immature HIV-1 assembly and the mechanistic...